RAC2 and prostate cancer: Downregulation of KBTBD7 was demonstrated to inhibit cell proliferation and invasion of non-small cell lung cancer cells in vitro [36] and small interfering RNA-mediated knockdown of RAC2 demonstrated antiproliferative and proapoptotic effects in prostate cancer cells [37].